Appropriateness of the National Academy of Clinical Biochemistry recommendation of repeating HbA1c analysis for extreme results in clinical practice

This version was published on 1 March 2009

Ann Clin Biochem 2009;46:165-166
doi:10.1258/acb.2008.008153
© 2009 Association for Clinical Biochemistry

 

This Article
Right arrow
Full Text
Right arrow

Full Text (PDF)

Right arrow
All Versions of this Article:

acb.2008.008153v1

46/2/165

most recent

Right arrow
Alert me when this article is cited
Right arrow
Alert me if a correction is posted
Services
Right arrow
Email this article to a friend
Right arrow

Similar articles in this journal

Right arrow
Similar articles in PubMed
Right arrow
Alert me to new issues of the journal
Right arrow
Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow
Articles by Yalamati, P
Right arrow
Articles by Twomey, P J
Right arrow Search for Related Content
PubMed
Right arrow
PubMed Citation
Social Bookmarking

What’s this?

Short Reports


P Yalamati,
B J Jones and
P J Twomey


Department of Clinical Biochemistry, The Ipswich Hospital, Ipswich, Suffolk IP4 5PD, UK


Corresponding author: Dr Patrick J Twomey. Email: ptwomey{at}nhs.net


Background: The National Academy of Clinical Biochemistry (NACB) recommends that the presence of a variant or modified haemoglobin be considered when any HbA1c result is below the lower limit of the reference interval or ≥15%. In those instances where a variant haemoglobinis suspected, repeat measurement using an alternative methodis the usual course of action. In the present study, we undertookto determine the impact of this guideline on our identificationof variant and modified haemoglobins.

Methods: All requests for HbA1c estimation received over a 32-month period,and which gave a result of <4% or >15% were re-analysedby a different method and the results compared.

Results: Over the 32-month period, 94 samples with a HbA1c result of <4% or ≥15% were identified. Of these, 80 were re-analysedusing a different method. No chromatographic abnormalities wereseen and there were no significant differences between the resultsobtained using the two methods.

Conclusions: No variant or modified haemoglobins were identified in thisstudy and this observation is likely to be representative ofthe ethnic makeup of our patient population. On the basis ofthis finding, we recommend that laboratories consider localfactors when deciding whether to comply with the NACB guidelines.


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What’s this?